Dissident Shareholder Goggin Wins Seat on Vermillion's Board of Directors | GenomeWeb

NEW YORK (GenomeWeb News) – Vermillion said in a US Securities and Exchange Commission filing released after the close of the market yesterday that its shareholders elected Robert Goggin to the company's board of directors at the firm's annual meeting last week.

Goggin, who was put forth as a candidate by a trio of dissident shareholders comprising himself, Gregory Novak, and George Bessenyei, defeated Vermillion's candidate, Roberta Della Vedova, with 4,749,042 votes cast for Goggin compared to 3,938,399 for Vedova.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.